motor effect

motor effect

[′mōd·ər i‚fekt]
(electromagnetism)
The mutually repulsive force exerted by neighboring conductors that carry current in opposite directions.
Mentioned in ?
References in periodicals archive ?
The insertion of the catheter at the subdural level leads to the spread of the anesthetic to the subarachnoid space, leading to a sensory block that affects the more cephalic metameres for the volume and concentration used with a variable motor effect and even cardiorespiratory arrest.
The visuo-cognitive and motor effect of amantadine in non-Caucasian patients with Parkinson's disease.
The maximum motor effect is reached 60 min after L-DOPA administration.
In the case of restricted block (sensitivity 100%), the criteria include a start after more than 20 min and sensory involvement with minimum or absent motor effect.
* Duration of motor blockade was defined as between the onset of peak motor effect and the onset of weaning of motor effect in any of the nerve distribution.
In the time course analyses on treatment Day 15, it appeared that zonisamide enhanced and prolonged the motor effects of levodopa, although peak-dose dyskinesia got slightly worsened.
Our study explored possible sensory and motor effects of anodal tDCS and HD-tDCS targeting M1.
This study showed that 0.5% hyperbaric bupivacaine had faster onset of sensory and motor effects while 0.5% isobaric levobupivacaine had comparable extent of sensory blockade and effective (Grade 3) motor block.
Title: "Motor Effects and Safety of IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa, in Advanced Parkinson's Disease: A Single Dose Study" (Poster presentation, PN-3964, Authors: Mark Stacy, M.D.; Victor Biton, M.D.; Jason Aldred, M.D.; Aaron Ellenbogen, M.D.; Robert Rubens, M.D., MBA; Nishit B.
She said she uses first-line clozapine, which is more effective for delusions than quetiapine and has fewer adverse motor effects. She said she has not yet used pimavanserin (Nuplazid), a selective 5-hydroxytryptamine receptor 2A inverse agonist that in April 2016 became the first drug approved by the Food and Drug Administration for treating hallucinations and delusions in Parkinson's disease.
For those variables studies exposed that induction motor effects are very sensitive to short interruptions and voltage sags (Bollen, Hager & Roxenius, 2003; Guasch Pesquer, Corcoles, & Pedra, 2000; Guasch Pesquer, Corcoles, & Pedra, 2004; Pedra, Sainz, & Corcoles, 2007).
She said she uses first-line clozapine, which is more effective for delusions than quetiapine and has fewer adverse motor effects. She said she has not yet used pimavanserin (Nuplazid), a selective 5-[HT.sub.2A] inverse agonist that in April 2016 became the first drug approved by the Food and Drug Administration for treating hallucinations and delusions in Parkinson's disease.